Suzanne P. Linn-Rasker

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort study

F. van Gaalen, Suzanne P. Linn-Rasker, W J van Venrooij et al. · Arthritis & Rheumatism · 2004 · 642 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles

Suzanne P. Linn-Rasker · Annals of the Rheumatic Diseases · 2005 · 321 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

The Starting Dose of Levothyroxine in Primary Hypothyroidism Treatment

Annemieke Roos, Suzanne P. Linn-Rasker, Ron T. van Domburg et al. · Archives of Internal Medicine · 2005 · 151 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +13

Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA study

Marije F. Bakker, Johannes W. G. Jacobs, Paco M J Welsing et al. · Annals of the Rheumatic Diseases · 2011 · 53 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Arthritis of the large joints—in particular, the knee—at first presentation is predictive for a high level of radiological destruction of the small joints in rheumatoid arthritis

Suzanne P. Linn-Rasker, Annette H M van der Helm–van Mil, F. C. Breedveld et al. · Annals of the Rheumatic Diseases · 2006 · 51 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +13